Alpha Tau Medical (DRTS) Current Assets (2020 - 2026)

Alpha Tau Medical (DRTS) has 7 years of Current Assets data on file, last reported at $81.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 43.25% year-over-year to $81.3 million; the trailing twelve-month figure through Mar 2026 stood at $81.3 million (up 43.25% YoY), and the FY2025 full-year result was $78.3 million, up 21.9% from the prior year.
• Current Assets rose to $81.3 million in Q1 2026, from $78.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $111.2 billion in Q1 2022 to a low of $56.8 million in Q1 2025.
• A 5-year average of $6.6 billion and a median of $85.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 226.21% in 2022 and tumbled 99.91% in 2023, its largest moves.
• Tracing DRTS's Current Assets over 5 years: stood at $106.5 million in 2022, then declined by 19.46% to $85.8 million in 2023, then declined by 25.1% to $64.2 million in 2024, then rose by 21.9% to $78.3 million in 2025, then grew by 3.9% to $81.3 million in 2026.
• Business Quant data shows DRTS's Current Assets at $81.3 million in Q1 2026, $78.3 million in Q4 2025, and $77.1 million in Q3 2025.